ArticlePharmaceuticals (Basel, Switzerland)2023

STA9090 as a Potential Therapeutic Agent for Liver Fibrosis by Modulating the HSP90/TβRII/Proteasome Interplay: Novel Insights from In Vitro and In Vivo Investigations.

Osama A Mohammed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.